logo
Clinical Advances in Multiple Myeloma From ASCO 2025

Clinical Advances in Multiple Myeloma From ASCO 2025

Medscape23-06-2025
The coming of age of chimeric antigen receptor (CAR) T-cell therapy, the selection of postinduction therapy on the basis of residual disease activity, and a novel drug delivery system are among the developments in multiple myeloma (MM) presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
Dr Joseph Mikhael, from City of Hope Cancer Center in Phoenix, Arizona, opens with long-term follow-up data from the CARTITUDE-1 trial of ciltacabtagene autoleucel CAR T-cell therapy in heavily pretreated relapsed/refractory MM. One third of patients remained progression free for 5 or more years following a single infusion, offering hope of a cure.
Next, he discusses the MIDAS trial of newly diagnosed MM, in which the treatment choice was driven by residual disease activity after induction therapy. The results indicated that autologous stem cell transplant may not be beneficial in patients with no residual disease activity and could potentially be avoided.
Dr Mikhael then turns to follow-up from PERSEUS, again in newly diagnosed disease. The data showed daratumumab to be a key component of both induction therapy when combined with bortezomib, lenalidomide, dexamethasone, and maintenance therapy in combination with lenalidomide.
In closing, he discusses a German trial that underlined the importance of aggressive treatment in high-risk newly diagnosed MM as well as an analysis of an on-body delivery system for subcutaneous isatuximab that met with patient satisfaction.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

HR Exec Who Was Seen Wrapped in CEO's Arms in Viral Coldplay Video Remains in Role as Company Moves Forward
HR Exec Who Was Seen Wrapped in CEO's Arms in Viral Coldplay Video Remains in Role as Company Moves Forward

Yahoo

time21 minutes ago

  • Yahoo

HR Exec Who Was Seen Wrapped in CEO's Arms in Viral Coldplay Video Remains in Role as Company Moves Forward

While Astronomer CEO Andy Byron resigned over the weekend after he was seen wrapping his arms around one of his female executives at a concert, she appears to still be with the company as new leadership is vowing to move forward. Kristin Cabot, Astronomer's chief people officer, was caught in the now-infamous clip with Byron in the audience at a Coldplay show in Massachusetts last week. Their unusual reaction — she quickly turned her back to the so-called "kiss cam" and he ducked out of sight — led Martin to joke that 'either they're having an affair or they're just very shy.' Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer​​, from celebrity news to compelling human interest stories. Both Byron and Cabot are reportedly married; neither has spoken publicly about the nature of their relationship. As of Wednesday, July 23, Cabot is still listed on the company website in her role as chief people officer, though Byron has been removed. (Efforts to reach her for comment have been unsuccessful.) An Astronomer spokesman previously said that "no other employees were in the video." The entire imbroglio spawned countless memes and mockery and put a national spotlight, for a few days, on the former colleagues. Many online purported to dig up and share personal details about both of their families. The controversy was also the subject of much discussion about the nature of privacy in a digital age and what behavior should and shouldn't subject someone to public scrutiny. In a press release in November announcing Cabot's hiring at Astronomer, Byron was quoted as saying her 'exceptional leadership and deep expertise in talent management, employee engagement, and scaling people strategies will be critical as we continue our rapid trajectory. She is a proven leader.' In a statement after Byron stepped down titled "Moving Forward at Astronomer," his replacement, Pete DeJoy, acknowledged that 'the events of the past few days have received a level of media attention that few companies—let alone startups in our small corner of the data and AI world—ever encounter." All of the attention had been 'unusual and surreal for our team,' DeJoy said, 'and, while I would never have wished for it to happen like this, Astronomer is now a household name." Read the original article on People

Push for new hospital in Dayton rejected by commissioners
Push for new hospital in Dayton rejected by commissioners

Yahoo

time21 minutes ago

  • Yahoo

Push for new hospital in Dayton rejected by commissioners

A proposal for a new tax levy to fund a public hospital in West Dayton will not appear on the November ballot after a deadlocked vote by the Dayton City Council. [DOWNLOAD: Free WHIO-TV News app for alerts as news breaks] The proposal, which aimed to establish a one-mill tax levy to generate $2 million annually, was intended to replace the services lost when Premier Health closed the Good Samaritan Hospital. 'There has been no site identified for this project; the funding is woefully insufficient,' Dayton City Commissioner Chris Shaw said. Bishop Richard Cox of the Clergy Community Coalition appealed to the council, saying, 'We appeal to your compassion, we appeal to your graciousness.' TRENDING STORIES: Bryan Kohberger sentenced; families of murder victims make emotional impact statements Health network announces 2023 data breach New Survey: Local village has one of the best main streets in America to take a walk 'We've jumped through all the hoops. Put it on the ballot. Let the voters decide,' Kathleen Gaul of the Clergy Community Coalition said. The Clergy Community Coalition, which has been advocating for the levy, argues that residents of North and West Dayton need hospital care closer to their homes after the closure of Good Samaritan Hospital. Despite the coalition's efforts, including gathering 1,250 valid signatures to qualify the issue for the ballot, the council's 2-2 vote with one abstention prevented the measure from moving forward. Nancy Kiehl of the Clergy Community Coalition expressed frustration with the council's decision. 'We will do this, and we'll do your job because you failed to do your job,' Kiehl said. Commissioners defended their decision, emphasizing the need to protect taxpayers and city budgets. 'You can't just say, we hope it's going to happen or we think it's going to happen,' Commissioner Matt Joseph said. Shaw highlighted the potential financial impact on the city, noting that filling the funding gap could necessitate cuts to essential services like police, fire, and public works. The deadlock in the Dayton City Council has stalled efforts to bring the tax levy proposal to voters. [SIGN UP: WHIO-TV Daily Headlines Newsletter] Solve the daily Crossword

Neuralink targets $1 billion revenue by 2031, Bloomberg News reports
Neuralink targets $1 billion revenue by 2031, Bloomberg News reports

Yahoo

time21 minutes ago

  • Yahoo

Neuralink targets $1 billion revenue by 2031, Bloomberg News reports

(Reuters) -Elon Musk's brain implant company Neuralink aims to generate at least $1 billion in annual revenue by 2031, driven by plans to perform 20,000 surgeries per year, Bloomberg News reported on Wednesday, citing investor documents. The company aims to operate five large clinics within six years and offer three versions of its brain device, including Telepathy for communication between the brain and machines, Blindsight for restoring vision, and Deep for treating tremors and Parkinson's disease, according to the report. Neuralink did not immediately respond to a Reuters request for comment. The company expects regulatory approval for its Telepathy device by 2029, with plans to perform 2,000 surgeries annually and generate $100 million in revenue, the report said. By 2030, Neuralink anticipates launching Blindsight, expanding surgeries to 10,000 per year and generating over $500 million in revenue. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store